Global Hematology and Flow Cytometry Markets: Growth Opportunities and Strategies

Jan. 4, 2012 - PRLog -- Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to add a new report to its collection of Diagnostics Market Research and Technology Assessments publications.

"Global Hematology and Flow Cytometry Markets: Growth Opportunities and Strategies" http://www.vpgmarketresearch.com/Hematology-Flow-Cytometry is a seven-country, 700-page report designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the hematology and flow cytometry market during this decade.

This report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next ten years. The report explores future marketing and technological trends in seven countries; provides market share estimates, test volume forecasts, and instrument placements; compares features of over 60 analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.

To review or order this report, visit http://www.vpgmarketresearch.com/the-hematology-and-flow-...

Contact

Robert Fisher
Healthcare Research
robert@vpgcorp.com
+1 212 564 2838
http://www.VPGMarketResearch.com

VPG Research Store
About VPG
Clients

Table of Contents

Worldwide Market and Technology Overview

A. Major Routine and Special Hematology Tests
1. Introduction
2. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
° MCV
° RDW
° MCHC
° CHCM
° HDW
° MCH
e. Red Cell Size Histograms
f. Platelets
° Platelet Count
° Platelet Size/MPV
° PDW
° Automated Systems
3. White Blood Cell Analysis
a. WBC Count
b. Five-Partial Differential
° Siemens Advia
° Beckman Coulter VCS
° Sysmex X-Class
° Abbott Cell-DYN Series
° Pattern Recognition Systems
* IRIS Diagnostics
° Comparison of Major Differential
Analyzers
4. Reticulocytes
5. Platelet Function Tests
6. Erythrocyte Sedimentation Rate
7. Red Cell Analysis
8. DPG
9. Red Cell Deformability
10. Neutrophil Function Tests
11. Semen Analysis
12. Bone Marrow Analysis
13. Urinalysis

B. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8
° Instrumentation and
Reagent Test Kits
* BD FACS Count
* Beckman Coulter VCS
* T Cells Diagnostics TRAx
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Reticulocytes
7. Chromosome Analysis
8. Fetal Cell Analysis
9. HLA Typing
10. Microbiology
11. Protein Content Analysis
12. Multiparameter Analysis
13. Other Applications

C. Instrumentation Review
1. Hematology Analyzers
a. Overview
° Electrical Aperture-Impedance
Analyzers
° Light Scatter Analyzers
b. System Review
° Abbott Cell-Dyn 1800
° Abbott Cell-Dyn 3000
° Abbott Cell-Dyn 3200
° Abbott Cell-Dyn 3500
° Abbott Cell-Dyn 3700
° Abbott Cell-Dyn Ruby
° Abbott Cell-Dyn Sapphire
° Abbott Cell-Dyn Emerald
° Beckman Coulter Ac?T diff
° Beckman Coulter Ac?T diff2
° Beckman Coulter HmX
° Beckman Coulter LH 500
° Beckman Coulter LH 750
° Beckman Coulter LH 780
° Beckman Coulter LH 1500
° Beckman Coulter STKS
° Beckman Coulter UniCell DxH 800
° Biocode Hycel Celly Plus
° Biocode Hycel 9000
° Drew-Scientific 2280
° Drew-Scientific Excell 16 and 18
° Horiba ABX Helios LMG/5DIFF
° Horiba ABX Micros Series
° Horiba ABX Pentra Series
° Menarini BC Series
° Nihon Kohden MEK Series
° Siemens ADVIA/H Series
° Siemens Advia 120
° Siemens Advia 2120i
° Sysmex XE-2100
° Sysmex XE-5000
° Sysmex XE-AlphaN
° Sysmex HST-N
° Sysmex NE-8000
° Sysmex pocH-100i
° Sysmex SE-9000
° Sysmex VES-Matic Cube 200
° Sysmex XT Series
2. Flow Cytometers
a. Introduction
b. System Overview
° BD FACSadvantage
° BD FACSAria III
° BD FACSCalibur
° BD FACScan
° BD FACSCanto II
° BD FACSCount
° BD FACSort
° BD FACStar Series
° BD FACStrak
° BD FACS Vantage
° BD Influx
° Beckman Coulter Epics C
° Beckman Coulter Epics Elite Analyzer
° Beckman Coulter Epics Elite ESP
° Beckman Coulter Epics Profile
° Beckman Coulter Epics XL
° Beckman Coulter FC 500 Series
° Beckman Coulter Vi-CELL XR
3. Platelet Aggregometers
4. Sedimentation Rate Analyzers
° Diesse Ves Matic
° Polymedco Sedimat

D. Current Market Needs and Future Demand for
Hematology Analyzers

E. Reagents and Controls

F. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology

G. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
III. France
IV. Germany
V. Italy
VI. Japan
VII. Spain
VIII. U.K.
IX. U.S.
X. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XIII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. Competitive Assessments
° Abbott
° Beckman Coulter
° Becton Dickinson
° Bio-Rad
° DakoCytomation
° Horiba
° Iris
° J&J Diagnostics
° Nihon Kohden
° Roche
° Siemens
° Sysmex

XV. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications

Contact

Robert Fisher
Healthcare Research
robert@vpgcorp.com
+1 212 564 2838
http://www.VPGMarketResearch.com

# # #

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavors & Fragrances, Food & Beverage, Electronics, and other industries.

During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of worldwide contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

Specialties
Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/Joint Venture Evaluations.